Back

Junctional Adhesion Molecule-A (JAM-A) polymorphisms influence serum levels of soluble JAM-A and are associated with long term prognosis in coronary artery disease

2 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Coronary Artery Disease – Epidemiology, Prognosis, Outcome Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Dominik Rath

University Hospital of Tuebingen, Tuebingen (Germany)

10 More presentations in this session

Presentation thumbnail
Doctor D. Takagi (Kyouto, JP)
Abstract
Presentation thumbnail
Doctor N. Yousif (Manama, BH)
Presentation thumbnail
Assistant Professor J. Jang (Seoul, KR)
Abstract
Presentation thumbnail
Doctor T. Niwa (Toyohashi, JP)
Abstract
Presentation thumbnail
Doctor T. Unoki (Kumamoto, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Coronary Artery Disease – Epidemiology, Prognosis, Outcome

The Event

Event poster

ESC Congress 2019

2 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Association between genetic polymorphisms in multiple thrombosis-related genes and long-term prognosis in coronary artery disease patients: a large-scale cohort study
1 September 2025
thumbnail
Congress Presentation
Diabetes mellitus induces endothelial JAM-A upregulation, accelerating monocytic transmigration but not adhesion
1 September 2025
thumbnail
Congress Presentation
Circulating vascular cell adhesion molecule level is an independent predictor of adverse outcomes in HFrEF: findings from DAPA-HF
20 May 2023
thumbnail
Congress Presentation
SDMA correlates with platelet reactivity and bleeding risk in patients with acute coronary syndrome undergoing percutaneous coronary intervention
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources